DaVita Is Recognized for Clinical and Operational Excellence Early in 2011
March 04 2011 - 1:27PM
Business Wire
DaVita Inc. (NYSE: DVA), a leading provider of kidney care
services for those diagnosed with end stage renal disease (ESRD)
and chronic kidney disease (CKD), has been honored as one of the
2011 Fortune® World’s Most Admired Companies, and ranked second in
the Health Care: Medical Facilities industry. This marks the sixth
consecutive year that Fortune has recognized DaVita® among the
World’s Most Admired Companies. Among healthcare providers, DaVita
ranked first in innovation and quality of products and
services.
“DaVita is deeply committed to clinical innovation and teammate
(employee) training, which combine to help us deliver high-quality
care to our more than 125,000 patients,” said Kent Thiry, chairman
and CEO of DaVita.
Fortune’s Most Admired Companies list is the
definitive report card on corporate reputations. A total of 673
companies from 32 countries across 57 industries were surveyed to
create the lists. Approximately 4,100 senior executives, outside
directors and industry analysts were asked to rate companies in
their own industries on nine criteria, such as investment value and
social responsibility. To meet Fortune’s high standard for
recognition, a company's score must rank in the top half of its
industry.
DaVita also earned recognition for the seventh consecutive year
from Training Magazine as one of the Top 125 organizations that
excel at employee development. Training Magazine uses quantitative
and qualitative research that takes into consideration the
following criteria: organization site, training tied to business
objectives, leadership development and number of trainers.
In late March, which is National Kidney Month, the American
Association of Kidney Patients will present the AAKP Medal of
Excellence Award to Allen R. Nissenson, MD, FACP, chief medical
officer at DaVita. This prestigious honor recognizes nephrologists
who have made significant contributions to the advancement and
enhancement of patient care. Since joining DaVita in 2008, Dr.
Nissenson established National Quality Week and other communication
channels with medical directors to improve the quality and safety
of patient care; has been an influential public policy advocate for
kidney care patients; and helped promote early detection in the
broader community.
DaVita is a registered trademark of DaVita Inc. All other
trademarks are the property of their respective owners.
About DaVita
DaVita Inc., a Fortune 500® company, is a leading provider of
kidney care in the United States, delivering dialysis services and
education to patients with chronic kidney failure and end stage
renal disease. As of Dec. 31, 2010, DaVita operated or
provided administrative services at 1,612 dialysis facilities,
serving approximately 125,000 patients. DaVita develops,
participates in and donates to numerous programs dedicated to
transforming communities and creating positive, sustainable change
for children, families and our environment. The company’s
leadership development initiatives and corporate social
responsibility efforts have been recognized by Fortune, Modern
Healthcare, Newsweek and WorldBlu, among others. For more
information, please visit www.davita.com.
DaVita (NYSE:DVA)
Historical Stock Chart
From May 2024 to Jun 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Jun 2023 to Jun 2024